Analyses of SLC13A5-epilepsy patients reveal perturbations of TCA cycle

Matthew N. Bainbridge, Erin Cooney, Marcus Miller, Adam D. Kennedy, Jacob E. Wulff, Taraka Donti, Shalini N. Jhangiani, Richard A. Gibbs, Sarah H. Elsea, Brenda E. Porter, Brett H. Graham

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objective To interrogate the metabolic profile of five subjects from three families with rare, nonsense and missense mutations in SLC13A5 and Early Infantile Epileptic Encephalopathies (EIEE) characterized by severe, neonatal onset seizures, psychomotor retardation and global developmental delay. Methods Mass spectrometry of plasma, CSF and urine was used to identify consistently dysregulated analytes in our subjects. Results Distinctive elevations of citrate and dysregulation of citric acid cycle intermediates, supporting the hypothesis that loss of SLC13A5 function alters tricarboxylic acid cycle (TCA) metabolism and may disrupt metabolic compartmentation in the brain. Significance Our results indicate that analysis of plasma citrate and other TCA analytes in SLC13A5 deficient patients define a diagnostic metabolic signature that can aid in diagnosing children with this disease.

Original languageEnglish (US)
Pages (from-to)314-319
Number of pages6
JournalMolecular Genetics and Metabolism
Volume121
Issue number4
DOIs
StatePublished - Aug 1 2017
Externally publishedYes

Fingerprint

Citric Acid Cycle
Epilepsy
Citric Acid
Plasmas
Metabolome
Nonsense Codon
Brain Diseases
Missense Mutation
Metabolism
Mass spectrometry
Brain
Mass Spectrometry
Seizures
Urine

Keywords

  • Metabolomics
  • Seizure
  • SLC13A5
  • Tricarboxylic acid cycle

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Molecular Biology
  • Genetics
  • Endocrinology

Cite this

Bainbridge, M. N., Cooney, E., Miller, M., Kennedy, A. D., Wulff, J. E., Donti, T., ... Graham, B. H. (2017). Analyses of SLC13A5-epilepsy patients reveal perturbations of TCA cycle. Molecular Genetics and Metabolism, 121(4), 314-319. https://doi.org/10.1016/j.ymgme.2017.06.009

Analyses of SLC13A5-epilepsy patients reveal perturbations of TCA cycle. / Bainbridge, Matthew N.; Cooney, Erin; Miller, Marcus; Kennedy, Adam D.; Wulff, Jacob E.; Donti, Taraka; Jhangiani, Shalini N.; Gibbs, Richard A.; Elsea, Sarah H.; Porter, Brenda E.; Graham, Brett H.

In: Molecular Genetics and Metabolism, Vol. 121, No. 4, 01.08.2017, p. 314-319.

Research output: Contribution to journalArticle

Bainbridge, MN, Cooney, E, Miller, M, Kennedy, AD, Wulff, JE, Donti, T, Jhangiani, SN, Gibbs, RA, Elsea, SH, Porter, BE & Graham, BH 2017, 'Analyses of SLC13A5-epilepsy patients reveal perturbations of TCA cycle', Molecular Genetics and Metabolism, vol. 121, no. 4, pp. 314-319. https://doi.org/10.1016/j.ymgme.2017.06.009
Bainbridge, Matthew N. ; Cooney, Erin ; Miller, Marcus ; Kennedy, Adam D. ; Wulff, Jacob E. ; Donti, Taraka ; Jhangiani, Shalini N. ; Gibbs, Richard A. ; Elsea, Sarah H. ; Porter, Brenda E. ; Graham, Brett H. / Analyses of SLC13A5-epilepsy patients reveal perturbations of TCA cycle. In: Molecular Genetics and Metabolism. 2017 ; Vol. 121, No. 4. pp. 314-319.
@article{8574c543cdb9487f8177dfdc8b739c27,
title = "Analyses of SLC13A5-epilepsy patients reveal perturbations of TCA cycle",
abstract = "Objective To interrogate the metabolic profile of five subjects from three families with rare, nonsense and missense mutations in SLC13A5 and Early Infantile Epileptic Encephalopathies (EIEE) characterized by severe, neonatal onset seizures, psychomotor retardation and global developmental delay. Methods Mass spectrometry of plasma, CSF and urine was used to identify consistently dysregulated analytes in our subjects. Results Distinctive elevations of citrate and dysregulation of citric acid cycle intermediates, supporting the hypothesis that loss of SLC13A5 function alters tricarboxylic acid cycle (TCA) metabolism and may disrupt metabolic compartmentation in the brain. Significance Our results indicate that analysis of plasma citrate and other TCA analytes in SLC13A5 deficient patients define a diagnostic metabolic signature that can aid in diagnosing children with this disease.",
keywords = "Metabolomics, Seizure, SLC13A5, Tricarboxylic acid cycle",
author = "Bainbridge, {Matthew N.} and Erin Cooney and Marcus Miller and Kennedy, {Adam D.} and Wulff, {Jacob E.} and Taraka Donti and Jhangiani, {Shalini N.} and Gibbs, {Richard A.} and Elsea, {Sarah H.} and Porter, {Brenda E.} and Graham, {Brett H.}",
year = "2017",
month = "8",
day = "1",
doi = "10.1016/j.ymgme.2017.06.009",
language = "English (US)",
volume = "121",
pages = "314--319",
journal = "Molecular Genetics and Metabolism",
issn = "1096-7192",
publisher = "Academic Press Inc.",
number = "4",

}

TY - JOUR

T1 - Analyses of SLC13A5-epilepsy patients reveal perturbations of TCA cycle

AU - Bainbridge, Matthew N.

AU - Cooney, Erin

AU - Miller, Marcus

AU - Kennedy, Adam D.

AU - Wulff, Jacob E.

AU - Donti, Taraka

AU - Jhangiani, Shalini N.

AU - Gibbs, Richard A.

AU - Elsea, Sarah H.

AU - Porter, Brenda E.

AU - Graham, Brett H.

PY - 2017/8/1

Y1 - 2017/8/1

N2 - Objective To interrogate the metabolic profile of five subjects from three families with rare, nonsense and missense mutations in SLC13A5 and Early Infantile Epileptic Encephalopathies (EIEE) characterized by severe, neonatal onset seizures, psychomotor retardation and global developmental delay. Methods Mass spectrometry of plasma, CSF and urine was used to identify consistently dysregulated analytes in our subjects. Results Distinctive elevations of citrate and dysregulation of citric acid cycle intermediates, supporting the hypothesis that loss of SLC13A5 function alters tricarboxylic acid cycle (TCA) metabolism and may disrupt metabolic compartmentation in the brain. Significance Our results indicate that analysis of plasma citrate and other TCA analytes in SLC13A5 deficient patients define a diagnostic metabolic signature that can aid in diagnosing children with this disease.

AB - Objective To interrogate the metabolic profile of five subjects from three families with rare, nonsense and missense mutations in SLC13A5 and Early Infantile Epileptic Encephalopathies (EIEE) characterized by severe, neonatal onset seizures, psychomotor retardation and global developmental delay. Methods Mass spectrometry of plasma, CSF and urine was used to identify consistently dysregulated analytes in our subjects. Results Distinctive elevations of citrate and dysregulation of citric acid cycle intermediates, supporting the hypothesis that loss of SLC13A5 function alters tricarboxylic acid cycle (TCA) metabolism and may disrupt metabolic compartmentation in the brain. Significance Our results indicate that analysis of plasma citrate and other TCA analytes in SLC13A5 deficient patients define a diagnostic metabolic signature that can aid in diagnosing children with this disease.

KW - Metabolomics

KW - Seizure

KW - SLC13A5

KW - Tricarboxylic acid cycle

UR - http://www.scopus.com/inward/record.url?scp=85021648533&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021648533&partnerID=8YFLogxK

U2 - 10.1016/j.ymgme.2017.06.009

DO - 10.1016/j.ymgme.2017.06.009

M3 - Article

VL - 121

SP - 314

EP - 319

JO - Molecular Genetics and Metabolism

JF - Molecular Genetics and Metabolism

SN - 1096-7192

IS - 4

ER -